Alice Blue - 20 years of trust
    • ANT APP
    • ANT WEB
    • 1LyAlgos
    • 1lyOptions
    • TradingView
    • MTF
    • Insurance
    • IPO
    • Stocks
    • Mutual Funds
  • Partner with us
  • Trade School
  • Pricing

    • Pricing

    About Us

    • About Us

    Calculator

    • Calculators
    • Brokerage Calculator
    • MTF Calculator

    Resources

    • Blog
    • Webinars
    • Videos (YouTube)

    Updates

    • News
    • Trading Holidays
    • Cares
    • Media Coverage
    • Disclosures

    Support

    • Support
    • Refer & Earn
    CommunityCareers
Login
Top Gainers Today52 Weeks High StocksHistorical Returns StocksShare Market TodayTop Losers TodayStocks Market NewsPC JewellerVodafone IdeaEasy Trip Plann.Tata Gold ETFV2 RetailYes BankNip. India GoldSyncom Formul.SagilityNippon I SilverSalasar TechnoTata Silver ETFUrban CompanySuzlon EnergyOla ElectricIIFL FinanceAshoka BuildconTata Tele. Mah.Greaves Cotton
NIFTY 50NIFTY Midcap 100NIFTY 100NIFTY RealtySENSEXNIFTY AutoNIFTY PSU BankNIFTY FMCGNIFTY BANKNIFTY MIDCAP 150BSE EnergyNIFTY PharmaBSE 100 LargeCap TMCNIFTY NEXT 50NIFTY MetalBSE 500 QUALITY 50
Options Nifty 50Options BANK NIFTYOptions MIDCPNIFTYOptions FINNIFTYFutures Highest OIFutures OI GainersFutures OI LosersFutures Top Traded
Debt Mutual FundsBest Debt Mutual fundsBest Equity Mutual fundsBest Hybrid Mutual fundsBest MidCap Mutual fundsBest Multicap Mutual fundsBest Large Cap Mutual fundsBest Small Cap Mutual fundsBest ELSS Mutual fundsBest Contra Mutual fundsBest Value Mutual fundsBest Arbitrage Mutual fundsBest Dividend Yield Mutual fundBest Aggressive Mutual fundsBest Conservative Mutual funds
SIP CalculatorBrokerage CalculatorHome Loan EMI CalculatorLumpsum CalculatorMargin CalculatorFD CalculatorSWP CalculatorMF CalculatorEMI CalculatorStep-Up SIP CalculatorPPF Calculator
What Is IPO?Open IPOsUpcoming IPOsHow to Apply for an IPOWhat is Grey Market Premium?
Shares
Top Gainers Today52 Weeks High StocksHistorical Returns StocksShare Market TodayTop Losers TodayStocks Market NewsPC JewellerVodafone IdeaEasy Trip Plann.Tata Gold ETFV2 RetailYes BankNip. India GoldSyncom Formul.SagilityNippon I SilverSalasar TechnoTata Silver ETFUrban CompanySuzlon EnergyOla ElectricIIFL FinanceAshoka BuildconTata Tele. Mah.Greaves Cotton
Indices
NIFTY 50NIFTY Midcap 100NIFTY 100NIFTY RealtySENSEXNIFTY AutoNIFTY PSU BankNIFTY FMCGNIFTY BANKNIFTY MIDCAP 150BSE EnergyNIFTY PharmaBSE 100 LargeCap TMCNIFTY NEXT 50NIFTY MetalBSE 500 QUALITY 50
F&O
Options Nifty 50Options BANK NIFTYOptions MIDCPNIFTYOptions FINNIFTYFutures Highest OIFutures OI GainersFutures OI LosersFutures Top Traded
Mutual Funds
Debt Mutual FundsBest Debt Mutual fundsBest Equity Mutual fundsBest Hybrid Mutual fundsBest MidCap Mutual fundsBest Multicap Mutual fundsBest Large Cap Mutual fundsBest Small Cap Mutual fundsBest ELSS Mutual fundsBest Contra Mutual fundsBest Value Mutual fundsBest Arbitrage Mutual fundsBest Dividend Yield Mutual fundBest Aggressive Mutual fundsBest Conservative Mutual funds
Calculators
SIP CalculatorBrokerage CalculatorHome Loan EMI CalculatorLumpsum CalculatorMargin CalculatorFD CalculatorSWP CalculatorMF CalculatorEMI CalculatorStep-Up SIP CalculatorPPF Calculator
IPO
What Is IPO?Open IPOsUpcoming IPOsHow to Apply for an IPOWhat is Grey Market Premium?

Company
  • About Us
  • Work with Us
  • Terms and Conditions
  • EKYC Guidelines
  • Contact Us
  • Cares
Apps and Products
  • ANT APP
  • ANT WEB
  • 1LYOptions
  • Trade School
  • TradingView
  • 1LyAlgos
Calculators
  • Calculators
  • SIP Calculator
  • Mutual Funds Return Calculator
  • Brokerage Calculator
  • RMS Live Updates
  • Term Coverage Calculator
Important Links
  • Pricing
  • KYC Tracker
  • Market News
  • Global Indices
  • Gold Rate
  • Silver Rate
  • Trading Holidays

Alice Blue
3rd Floor, M.R.B.Arcade, No. 153/2,
Bagalur Main Rd, Dwarka Nagar,
Yelahanka, Bengaluru, Karnataka
560063
FacebookLinkedInX (Twitter)YouTubeInstagramWhatsapp

ISO 27001:2022 Alice Blue is Certified Information Security Management System (ISMS)

ISO 22301:2019 Alice Blue is Certified Business Continuity Management System (BCMS)

DownloadsCircularsBank DetailsLearn
Trade on TradingViewGet it on Google PlayDownload on the App Store

Attention Investors!
Prevent unauthorized transactions in your account update your mobile number/ email Id with your Stock Broker. Receive information of your transactions directly from Exchange on your mobile / email id at the end of the day.Prevent unauthorized transactions in your account update your mobile number/ email Id with your Stock Broker. Receive information of your transactions directly from Exchange on your mobile / email id at the end of the day.

Stock Brokers can accept securities as margin from clients only by way of pledge in the depository system w.e.f. September 1, 2020. Update your mobile number & email Id with your stock broker/depository participant and receive OTP directly from the depository on your email id and/or mobile number to create a pledge. Pay 20% upfront margin of the transaction early to trade in the cash market segment. Investors may please refer to the Exchange’s Frequently Asked Questions (FAQs) issued vide circular reference NSE/INSP/45191 dated July 31, 2020, and NSE/INSP/45534 dated August 31, 2020, and other guidelines issued from time to time in this regard. Check your Securities /MF/ Bonds in the consolidated account statement issued by NSDL/CDSL every month.

Corporate Office: No. 153/2, 3rd Floor, M.R.B.Arcade, Bagalur Main Road, Dwaraka Nagar, Yelahanka, Bengaluru – 560 063, Karnataka.
Registered Office: Old No.56/2 ,New No.58, LIC Nagar, Vinayagar Kovil Street, Erode -8,Tamil Nadu– 638002.
Alice Blue Financial Services (P) Ltd : NSE EQ | NSE FO | NSE CDS-90112 SEBI REG : INZ000156038
Alice Blue Financial Services (P) Ltd : BSE EQ | BSE FO | BSE CD-6670 SEBI REG : INZ000156038
Alice Blue Financial Services (P) Ltd : CDSL DP ID 12085300 DP SEBI REG : IN-DP-364-2018
Alice Blue Financial Services (P) Ltd : MCX-56710 SEBI REG : INZ000156038

COMPLIANCE OFFICER: SARAVANAN R | Mobile No: +91 91872 10670 | Email:[email protected]

We hereby declare that we are doing PRO trading

Procedure to file a complaint on SEBI SCORES / SMART ODR : Register on SEBI SCORES 2.0 / SMART ODR. Mandatory details for filing complaints on SCORES: Name, PAN, Address, Mobile Number, E-mail ID. Benefits: Effective Communication, Speedy redressal of the grievances

Click on the provided link to learn about the process for submitting a complaint on the ODR platform for resolving investor grievances. ODR Circular

Investment in securities markets are subject to market risks, read all the related documents carefully before investing. Brokerage will not exceed SEBI prescribed limit.

For queries regarding account opening or activation, email to accountactivation@aliceblueindia.com and for fund updates, email to funds@aliceblueindia.com

Disclaimer: Attention investors:1) Message from Exchange(s): Prevent Unauthorised transactions in your account --> Update your mobile numbers/email IDs with your stock brokers. Receive information of your transactions directly from Exchange on your mobile/email at the end of the day. Issued in the interest of investors. 2) Message from Depositories: a) Prevent Unauthorized Transactions in your demat account --> Update your mobile number with your Depository Participant. Receive alerts on your registered mobile for all debit and other important transactions in your demat account directly from CDSL on the same day issued in the interest of investors. b) KYC is one time exercise while dealing in securities markets - once KYC is done through a SEBI registered intermediary (broker, DP, Mutual Fund etc.), you need not undergo the same process again when you approach another intermediary. 3) Registration granted by SEBI and certification from NISM in no way guarantee performance of the intermediary or provide any assurance of returns to investors. 4) For demat and trading account closure with AliceBlue, kindly visit https://aliceblueonline.com/support/closure-freezing-reactivation or “ANT APPLICATION” under your profile and click on Settings -> Account Closure section -> Initiate account closure.

No need to issue cheques by investors while subscribing to an IPO. Just write the bank account number and sign in the application form to authorise your bank to make payment in case of allotment. No worries for refund as the money remains in the investor’s account.

Investors are requested to note that Alice Blue Financial Services Private Limited is permitted to receive money from investor through designated bank accounts only named as Up streaming Client Nodal Bank Account (USCNBA). Alice Blue Financial Services Private Limited is also required to disclose these USCNB accounts to Stock Exchange. Hence, you are requested to use following USCNB accounts only for the purpose of dealings in your trading account with us. The details of these USCNB accounts are also displayed by Stock Exchanges on their website under “Know/ Locate your Stock Broker. Bank Details (Valid UPI FAQ).

DND PolicyInvestor CharterLegal DocumentationPrivacy policyFeedbackAnnual ReturnsAdvisory for InvestorsE-votingMandatory Member Details
D

Dr Agarwal's Health Care Ltd

Complete IPO details, including price band, financials, subscription status, and key insights.

Participate in the Dr Agarwal's Health Care Ltd IPO with full transparency. Review issue details, company fundamentals, and financial performance, and apply securely through Alice Blue.

Apply for IPO

IPO Snapshot

Key metrics and details at a glance.

Price Band

₹402

Per Share

Lot Size

35 Shares

Minimum Investment

₹14,070

Issue Size

₹3,027.26 Cr

Face Value

₹1

Per Share

IPO Type

Book Building

Retail Quota

35%

QIB Quota

50%

NII Quota

15%

IPO Timeline

Important dates for your applying strategy.

IPO Opens29 Jan
IPO Closes31 Jan
Basis of Allotment1 Feb
Refund Initiation3 Feb
Shares Credited3 Feb

Dr Agarwals Health Care Ltd

Business model, operations, and market positioning.

Promoter Holding (Pre-Issue)

37.72%

Promoter Holding (Post-Issue)

32.45%

Issue Type

Book Building

ISIN

INE943P01029

About the Company

We provide a comprehensive range of eye care services, including cataract, refractive and other surgeries; consultations, diagnoses and non-surgical treatments; and sell opticals, contact lens and accessories, and eye care related pharmaceutical products. We endeavour to address all the needs of our patients in their eye treatment journey through a network, which as of September 30, 2024, comprised 209 Facilities.

Industry Overview

According to the CRISIL MI&A Report, the eye care market in India has grown at a compounded annual growth rate of 11.5 % between the Financial Years 2019 and 2024 to reach the value of ?378 billion in the Financial Year 2024. This market includes surgical and non-surgical treatments for patients suffering from various eye disorders. Surgical treatments in this industry includes cataract surgery, glaucoma, retina surgeries, refractive surgeries, cornea and other eye related surgeries. Cataract surgery has the largest share of eye care surgery in India. Non-surgical treatments in the industry include general checkups, pre-treatment assessment, post-treatment follow ups, diagnostics etc.

Financial Performance

Revenue, profit after tax and total assets across the last 3 reported financial years.

Consolidated figures
Financial Performance Categories

Revenue

▲+56.1%vs FY24

Amount in ₹ crore

Objects of the Issue

How the company plans to utilize IPO proceeds.

Use of Proceeds

The funds raised through this IPO will be used for:

Initial public offer of up to 75,304,970 equity shares of face value of Re. 1/- each ("Equity Shares") of Dr. Agarwal's Health Care Limited ("Company") for cash at a price of Rs. 402.00 per equity share (including a share premium of Rs. 401.00 per equity share) ("Offer Price") aggregating up to Rs. 3027.26 crores comprising a fresh issue of up to 74,62,686 equity shares of face value of Re. 1/- aggregating up to Rs. 300.00 crores by the company ("Fresh Issue") and an offer for sale of up to 67,842,284 equity shares of face value of Re. 1/- aggregating up to Rs. 2727.26 crores ("Offered Shares") by the selling shareholders, consisting of up to 2,176,239 equity shares of face value of Re. 1/- aggregating up to Rs. 87.48 crores by Amar Agarwal, up to 2,629,829 equity shares of face value of Re. 1/- aggregating up to Rs. 105.72 crores by Athiya Agarwal, up to 3,071,188 equity shares of face value of Re. 1/- aggregating up to Rs. 123.46 crores by Adil Agarwal, up to 3,614,508 equity shares of face value of Re. 1/- aggregating up to Rs. 145.30 crores by Anosh Agarwal, up to 241,269 equity shares of face value of Re. 1/- aggregating up to Rs. 9.70 crores by Ashvin Agarwal, up to 1,883,869 equity shares of face value of Re. 1/- aggregating up to Rs. 75.73 crores by Agarwal's Eye Institute (collectively "The Promoter Selling Shareholders"), up to 7,083,010 equity shares of face value of Re. 1/- aggregating up to Rs. 284.74 crores by Arvon Investments Pte. Ltd., up to 16,148,150 equity shares of face value of Re. 1/- aggregating up to Rs. 649.16 crores by Claymore Investments (Mauritius) Pte. Ltd., and up to 30,755,592 equity shares of face value of Re. 1/- aggregating up to Rs. 1236.37 crores by Hyperion Investments Pte. Ltd. (collectively the "Investor Selling Shareholders"), up to 119,315 equity shares of face value of Re. 1/- aggregating up to Rs. 4.80 crores by Farah Agarwal, up to 119,315 equity shares of face value of Re. 1/- aggregating up to Rs. 4.80 crores by Urmila Agarwal (collectively the "Other Selling Shareholders") (the promoter selling shareholders, the other selling shareholders and the investor selling sharehodlers, collectively referred to as the "Selling Shareholders") and such equity shares offered by the selling shareholders ("Offer for Sale", and together with the fresh issue, the "Offer"). The offer included a reservation of 1,579,399 equity shares of face value of Re. 1/-, aggregating to Rs. 63.49 crores (Constituting 0.50 % of the post-offer paid-up equity Share Capital), for subscription by eligible employees ("Employee Reservation Portion") and a reservation of 1,129,574 equity shares aggregating to Rs. 45.41 crores (Constituting 0.36 % of the post-issue paid-up Equity Share Capital) for subscription by eligible AEHL shareholders ("Shareholder Reservation Portion"). The offer less the employee reservation portion and the shareholder reservation is hereinafter referred to as the "Net Offer". The offer and the net offer constituted 23.84 % and 22.98 % of the post-offer paid-up equity share capital of the company, respectively. The face value of equity shares is Re. 1/- each. the offer price is 402 times the face value of the equity shares.

Strengths & Risks

Key competitive advantages and factors to consider before investing.

Strengths and Risk Factors
  • Largest eyecare services provider in India with a trusted brand.
  • End-to-end, comprehensive eyecare services offering.
  • Scalable, asset-light, hub-and-spoke operating model.

Frequently Asked Questions

01

What is the minimum investment required to apply for this IPO?

The minimum investment depends on the lot size and the upper price band of the issue. Investors must apply for at least one lot, and the total investment amount is calculated by multiplying the lot size by the upper price band.
02

How is IPO allotment decided?

IPO allotment is determined based on demand and SEBI guidelines. If the IPO is oversubscribed in the retail category, allotment is typically done through a computerized lottery system to ensure fair distribution among eligible applicants.
Listing Date4 Feb
IPO Process Completed

Subscription Status

Live demand across investor categories.

Track real-time subscription levels:

*Real-time data subject to exchange updates

Qualified Institutional Buyers (QIB)4.64x
Non-Institutional Investors (NII)0.40x
Retail Individual Investors (RII)0.41x
Overall Subscription1.55x

Company History

Our Company was incorporated as `Dr. Agarwal's Health Care Limited' at Chennai, Tamil Nadu as a public limited company under the Companies Act, 1956, pursuant to a certificate of incorporation dated April 19, 2010, issued by the Registrar of Companies, Tamil Nadu and Andaman and Nicobar Island at Chennai ("RoC") and commenced operations pursuant to a certificate for commencement of business dated May 29, 2010 issued by the RoC.

Products & Services

  • The Company provides a comprehensive range of eye care services, including cataract, refractive and other surgeries; consultations, diagnoses and non-surgical treatments; and sell opticals, contact lens and accessories,& eye care related pharma. products

Growth Strategy

  • Continued organic expansion of our network in India.
  • Strengthen our brand equity with community, patients, and doctors across India.
  • Undertake opportunistic acquisitions and restructuring to scale our operations, leveraging our experience of inorganic growth and integration
  • Attracting and retaining qualified doctors and paramedics through continuous training, knowledge sharing and upskilling.
  • Focus on improving profitability and Facility-level growth and enhancing operational efficiencies.

Customer Base

Wholesaler and Retailer

3,000
2,000
1,000
0
1,332
1,711
2,080
FY24FY25FY26

Profit After Tax (PAT)

▲+60.4%vs FY24

Amount in ₹ crore

150
100
50
0
83.1
83.5
133
FY24FY25FY26

Total Assets

▲+44.1%vs FY24

Amount in ₹ crore

5,000
4,000
3,000
2,000
1,000
0
2,754
3,681
3,970
FY24FY25FY26

Figures in ₹ crore, on a consolidated basis, as reported for FY24 to FY26.

*Subject to approvals and market conditions.

  • Proven clinical excellence driven by a strong clinical board and history of surgical innovations.
  • Doctor-promoters leading a team of qualified medical professionals and supported by an experienced management.
    • The company engage doctors through retainership arrangements and there is no assurance that its doctors will not prematurely terminate their arrangements with it. If the company is not able to attract and retain its doctors and other medical professionals, the company business, financial condition, results of operations and cash flows may be adversely affected.
    • The company business depends on the strength of the company brand equity and reputation. Failures to maintain and enhance its brand equity and reputation, including due to negative publicity, may adversely affect its business, reputation, financial condition, results of operations and prospects.
    • The company operates in a regulated industry, and its failures to comply with applicable safety, health, environmental, labor and other regulations, or to obtain or renew approvals, may adversely affect its business, reputation, financial condition, results of operations and cash flows.
    • A significant majority of its Facilities are located in the states of Tamil Nadu (in particular, Chennai), Maharashtra and Karnataka in India and any adverse developments in relation to these Facilities could adversely affect its business, financial condition, results of operations and cash flows.
    • The company is exposed to legal claims and regulatory actions arising from the provision of healthcare services and may be subject to liabilities arising from claims of malpractice and medical negligence which could adversely affect its business, financial condition, results of operations, cash flows, reputation and prospects.
    03

    When will I know if shares are allotted to me?

    Allotment status is usually finalized a few days after the IPO closes. Once finalized, shares are either credited to your Demat account (if allotted) or the blocked funds are released back to your bank account.
    04

    Can I modify or cancel my IPO application?

    Yes, you can modify or cancel your IPO application anytime before the IPO closing date. Changes can be made through your Alice Blue account, subject to exchange cut-off timings.
    05

    What happens if the IPO is oversubscribed?

    If the IPO receives more applications than the number of shares available, it is considered oversubscribed. In such cases, allotment in the retail category is done on a proportionate or lottery basis, and not all applicants may receive shares.